Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Kronos Bio to Present Clinical Update on Phase 1/2 Trial of globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
SAN MATEO, Calif. and CAMBRIDGE, Mass., May 22, 2024 Kronos Bio, Inc. , a company dedicated to developing small molecule therapeutics that address cancers and other diseases driven by.
SAN MATEO, Calif. and CAMBRIDGE, Mass., May 21, 2024 Kronos Bio, Inc. , a company dedicated to developing small molecule therapeutics that address cancers and other diseases driven by.